MyFinsight
Home
Blog
About
Contact
Download
Download image
Cash and cash
equivalents
$5,084,800K
(11.27%↑ Y/Y)
Accounts receivable, net
$2,052,800K
(27.55%↑ Y/Y)
Inventories
$1,686,800K
(39.94%↑ Y/Y)
Marketable securities
$1,523,300K
(-1.49%↓ Y/Y)
Prepaid expenses and
other current assets
$853,300K
(28.18%↑ Y/Y)
Total current assets
$11,201,000K
(16.72%↑ Y/Y)
Long-term marketable
securities
$5,712,300K
(11.83%↑ Y/Y)
Deferred tax assets
$2,897,900K
(24.31%↑ Y/Y)
Operating lease assets
$1,562,700K
(15.18%↑ Y/Y)
Property and equipment,
net
$1,520,300K
(23.82%↑ Y/Y)
Other assets
$1,236,600K
(23.75%↑ Y/Y)
Goodwill
$1,088,000K
(0.00%↑ Y/Y)
Other intangible
assets, net
$424,200K
(-48.64%↓ Y/Y)
Total assets
$25,643,000K
(13.80%↑ Y/Y)
Total liabilities and
shareholders equity
$25,643,000K
(13.80%↑ Y/Y)
Total shareholders
equity
$18,665,800K
(13.75%↑ Y/Y)
Total liabilities
$6,977,200K
(13.94%↑ Y/Y)
Accumulated other
comprehensive (loss) income
-$15,900K
(-112.44%↓ Y/Y)
Retained earnings
$13,560,000K
(41.15%↑ Y/Y)
Additional paid-in capital
$5,119,200K
(-23.28%↓ Y/Y)
Total current
liabilities
$3,861,200K
(8.32%↑ Y/Y)
Long-term operating lease
liabilities
$1,846,500K
(19.56%↑ Y/Y)
Other long-term
liabilities
$1,269,500K
(40.77%↑ Y/Y)
Common stock, 0.01 par
value 500,000,000...
$2,500K
(-3.85%↓ Y/Y)
Accrued expenses
$2,971,200K
(6.55%↑ Y/Y)
Accounts payable
$461,700K
(11.79%↑ Y/Y)
Other current
liabilities
$428,300K
(17.99%↑ Y/Y)
Back
Back
Balance Sheet
source: myfinsight.com
logo-vertex-inc-svg copy-svg
VERTEX PHARMACEUTICALS INC MA (VRTX)
logo-vertex-inc-svg copy-svg
VERTEX PHARMACEUTICALS INC MA (VRTX)